Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Active Cutaneous Lupus Erythematosus”

26 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 26 results

Large-scale testing (Phase 3)Study completedNCT01551069
What this trial is testing

Multicenter Study Assessing the Efficacy & Safety of Hydroxychloroquine Sulfate in Patients With Systemic Lupus Erythematosus or Cutaneous Lupus Erythematosus With Active Lupus Erythematosus Specific Skin Lesion

Who this might be right for
Cutaneous Lupus Erythematosus-Systemic Lupus Erythematosus
Sanofi 103
Testing effectiveness (Phase 2)Ended earlyNCT05879718
What this trial is testing

Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms.

Who this might be right for
Lupus Erythematosus, SystemicLupus Erythematosus, Cutaneous
Pfizer 8
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Testing effectiveness (Phase 2)Study completedNCT03134222
What this trial is testing

Study to Evaluate Safety and Efficacy of Filgotinib and Lanraplenib in Females With Moderately-to-Severely Active Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Cutaneous Lupus Erythematosus
Gilead Sciences 47
Testing effectiveness (Phase 2)Study completedNCT02770170
What this trial is testing

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

Who this might be right for
Lupus Nephritis
Boehringer Ingelheim 121
Early research (Phase 1)Study completedNCT04493541
What this trial is testing

Assess the Safety and Drug Levels of BMS-986256 in Participants With Active Cutaneous Lupus Erythematosus

Who this might be right for
Lupus Erythematosus, Cutaneous
Bristol-Myers Squibb 13
Early research (Phase 1)Looking for participantsNCT06647069
What this trial is testing

DR-0201 in Subjects With Autoimmune Diseases

Who this might be right for
SLESLE (Systemic Lupus)CLE+9 more
Dren Bio 36
Not applicableStudy completedNCT01923415
What this trial is testing

A Non-drug Study Profiling Cutaneous Lupus

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid
Janssen Research & Development, LLC 29
Not applicableEnded earlyNCT01559155
What this trial is testing

Role of Proteasomes in a Dermatological Autoimmune Disease: Bullous Pemphigoid

Who this might be right for
Pemphigoid, BullousPemphigusLupus Erythematosus, Cutaneous
Centre Hospitalier Universitaire de Nīmes 14
Testing effectiveness (Phase 2)Ended earlyNCT03958955
What this trial is testing

Efficacy and Safety of Delgocitinib Cream in Discoid Lupus Erythematosus.

Who this might be right for
Discoid Lupus Erythematosus
LEO Pharma 27
Early research (Phase 1)Study completedNCT01845740
What this trial is testing

Phase Ib Study of SC Milatuzumab in SLE

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, DiscoidLupus Erythematosus, Systemic+2 more
Gilead Sciences 22
Large-scale testing (Phase 3)Not Yet RecruitingNCT07332481
What this trial is testing

Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 202
Large-scale testing (Phase 3)Looking for participantsNCT05531565
What this trial is testing

A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Biogen 474
Testing effectiveness (Phase 2)Ended earlyNCT01466725
What this trial is testing

A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus
Celgene 5
Testing effectiveness (Phase 2)Study completedNCT01294774
What this trial is testing

Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus

Who this might be right for
Subacute Cutaneous Lupus Erythematosus
Novartis Pharmaceuticals 10
Testing effectiveness (Phase 2)Looking for participantsNCT06980805
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Cutaneous Lupus Erythematosus (CLE)

Who this might be right for
Subacute Cutaneous Lupus ErythematosusChronic Cutaneous Lupus Erythematosus
Immunovant Sciences GmbH 56
Testing effectiveness (Phase 2)Ended earlyNCT05591222
What this trial is testing

Study of Daxdilimab (HZN-7734) in Participants With Moderate-to-Severe Primary Discoid Lupus Erythematosus

Who this might be right for
Discoid Lupus Erythematosus
Amgen 72
Testing effectiveness (Phase 2)Study completedNCT01597050
What this trial is testing

Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions

Who this might be right for
Lupus Erythematosus, DiscoidLupus Erythematosus, Systemic
Rigel Pharmaceuticals 54
Not applicableStudy completedNCT02034344
What this trial is testing

Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers

Who this might be right for
Lupus Erythematosus, CutaneousLupus Erythematosus, SystemicLupus Erythematosus, Discoid+1 more
Janssen Research & Development, LLC 77
Testing effectiveness (Phase 2)Active Not RecruitingNCT04857034
What this trial is testing

Evaluate Efficacy and Safety of Deucravacitinib in Participants With Active Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)

Who this might be right for
Lupus Erythematosus, DiscoidLupus Erythematosus, Subacute Cutaneous
Bristol-Myers Squibb 74
Load More Results